Biorythmos Competitors

BioWaveis a Medtech company redefining pain management through our innovative, non-invasive technology that delivers powerful relief without drugs or surgery. We offer a range of products designed to meet the unique needs of different markets, delivering effective, customized pain relief solutions where they’re needed most. Our technology is backed by clinical evidence and real-world results, helping patients reduce pain, restore function, and reclaim their lives. Trusted by healthcare professionals, athletes, veterans, and individuals alike, BioWavetargets pain at its source to provide long-lasting results. The information, including but not limited to, text, graphics, images and other material contained herein are for informational purposes only. It is not intended to be a substitute for medical billing advice, professional medical advice, diagnosis, or treatment. Any information contained herein are subject to a full examination of the medical studies, FDA filings and medical literature that underlie the claims. Learn more at BioWave.com. https://biowave.com/terms-of-use/

Backed by $40M and elite Silicon Valley VCs and strategics, Health Rhythms is a pioneering AI/behavioral sensing solution addressing the dual crises in mental health: insufficient access and lack of intervention effectiveness measurement. The market now recognizes that there is no health without mental health. By combining the multi-dimensional sensing capabilities of mobile phones with the power of embedded and cloud computing platforms and novel AI algorithms, we continuously, objectively, and accurately measure mental health status for the very first time. We are realizing the vision of precision medicine for mental health by anticipating clinical deterioration before it reaches crisis proportions and by delivering personalized, just-in-time interventions based on each patient’s own behavioral profile. We have a head start advantage of 35 years of empirical evidence, 957 peer-reviewed papers between our four co-founders, a universally recognized best-in-class team, a robust IP portfolio, and the largest mental health AI data set. UCHealth ($6B) declared "Health Rhythms will change the face of care," and its number one strategic priority is to deploy our app to its 2.5M patients. Otsuka ($18B pharma) invested in Health Rhythms after assessing 500+ mental health companies, recognizing our potential to revolutionize the industry.

WellSync empowers digital healthcare companies, labs, pharmacies, large employers, and healthcare innovators to deliver scalable, white-labeled telehealth experiences.